Omniscient Secures USD 27.2M Series D to Accelerate Commercialization of AI-Enabled Brain Technology
Funding to scale FDA-cleared Quicktome® platform and drive next-generation personalized brain care globally SAN FRANCISCO, May 29, 2026 (GLOBE NEWSWIRE) — Omniscient (o8t®), a pioneer in AI-driven brain analysis technology, today announced it has secured $27.2 million (AU$41.1 million) in an oversubscribed Series D funding round. The round is co-led by OIF Ventures and the […]
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.